Wealth Enhancement Advisory Services, LLC Biocryst Pharmaceuticals Inc Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 37,766 shares of BCRX stock, worth $261,718. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,766
Previous 37,671
0.25%
Holding current value
$261,718
Previous $282,000
19.86%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BCRX
# of Institutions
314Shares Held
201MCall Options Held
930KPut Options Held
553K-
Vanguard Group Inc Valley Forge, PA20.5MShares$142 Million0.0% of portfolio
-
Black Rock Inc. New York, NY20MShares$138 Million0.0% of portfolio
-
State Street Corp Boston, MA8.51MShares$58.9 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.46MShares$58.7 Million9.06% of portfolio
-
Alkeon Capital Management LLC New York, NY5.71MShares$39.6 Million0.09% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.29B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...